Tanemura, Nanae http://orcid.org/0000-0002-1787-9571
Sasaki, Tsuyoshi
Sato, Junko
Urushihara, Hisashi
Funding for this research was provided by:
Research Foundation for Pharmaceutical Sciences
Article History
Received: 7 February 2020
Accepted: 22 February 2021
First Online: 12 March 2021
Declarations
:
: Because this was a retrospective study using publicly available official data published on the websites of EU regulatory agencies, none of the data included identifiable participants. Thus, according to local ethical guidelines, neither an ethical review nor informed consent was required.
: Not applicable.
: TS has received speakers’ honoraria from Daiichi Sankyo, Eli Lilly, Glaxo Smith Kline, Novartis, Janssen, Otsuka, Shionogi, Shire, Takeda, Taisho, and Tanabe Mitsubishi, and has also received research support from Novartis, Otsuka, Shionogi, and Taisho (from April 2014 to December 2019). HU is a consultant of Eisai and Boehringer Ingelheim. He has received a research grant from Shionogi and Senju pharmaceutical. Additionally, he has received research funds from Daiichi Sankyo, Tanabe Mitsubishi, and Astellas. No financial or non-financial benefits have been or will be received by NT or JS from any party related directly or indirectly to the subject of this article.